Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Parasitic Diseases Therapeutics Market: By Product: Antiprotozoal Therapeutics, Anthelminthic Therapeutics, Scabicides And Pediculicides Therapeutics; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments
Global Parasitic Diseases Therapeutics Market Outlook
The global parasitic diseases therapeutics market is expected to grow in the forecast period of 2021-2026 at a CAGR of about 5.2%. The market is primarily being driven by the rising initiatives and programs to eliminate parasitic diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Amebiasis, African sleeping disease, trichomoniasis, giardiasis, trypanosomiasis, leishmaniasis, and malaria are all parasitic diseases that need treatment. Based on the product, the parasitic diseases therapeutics market can be divided into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Antiprotozoal Therapeutics
- Anthelminthic Therapeutics
- Scabicides And Pediculicides Therapeutics
The EMR report looks into the regional parasitic diseases therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Protozoal, along with helminthic worm diseases, have raised the mortality and morbidity of prophylactic therapy. Preventive chemotherapy is used to monitor the spread within a population of helminthic infections. The high prevalence of malaria worldwide prompted researchers to develop different vaccines to prevent the disease from spreading. Researchers are also developing a variety of prophylactic vaccines to treat and prevent skin leishmaniasis and visceral leishmaniasis. The growing acceptance of these prophylactic vaccines for the prevention and control of parasite diseases is one of the key market developments on parasitic diseases, which would have a positive effect on the market growth.
The occurrence of protozoan, helminth, as well as ectoparasite infections, is rapidly rising. The number of individuals infected with whipworms and hookworms is increasing annually. The number of cases of African trypanosomiasis recorded has also increased considerably, particularly in countries in sub-Saharan Africa like Zambia, Tanzania, Uganda, and Malawi. Likewise, in parts of Central America, South America, and Mexico, the prevalence of Chagas disease is high. In addition, the prevalence of schistosomiasis is also rising globally. The increasing prevalence of these parasites will lead to a growing demand for the treatment of parasites. The antiprotozoal therapeutics segment accounted for the largest market share in 2020.
However, the challenges related to the discovery of antiparasitic drugs and disease diagnosis, increased drug resistance, lack of effective therapies, and side-effects may impede the development of the parasite diseases therapeutics industry in the coming years.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global parasitic diseases therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Pfizer Inc. (NYSE: PFE)
- Sanaria Inc.
- Others
The EMR report gives an in-depth insight into the parasitic diseases therapeutics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region |
| Breakup by Product | Antiprotozoal Therapeutics, Anthelminthic Therapeutics, Scabicides And Pediculicides Therapeutics |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Bayer AG (ETR: BAYN), F. Hoffmann-La Roche Ltd. (SWX: ROG), GlaxoSmithKline Plc (LON: GSK), Pfizer Inc. (NYSE: PFE), Sanaria Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Key Questions Answered in the Report
- How has the global parasitic diseases therapeutics market performed in the previous years (2016-2020)?
- What is the forecast assessment of the industry for 2021-2026?
- What are the major drivers of the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints of the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major price indicators of the global parasitic diseases therapeutics market?
- What are the major demand indicators of the global industry?
- Who are the key manufacturers in the global parasitic diseases therapeutics market?
- What is the degree of competition in the global industry?
- What are the major events and developments taking place within the global industry?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Parasitic Diseases Therapeutics Market Analysis
6.1 Figure: Global Parasitic Diseases Therapeutics Historical Market (2016-2020) & Forecast (2021-2026)
6.2 Chart: Global Parasitic Diseases Therapeutics Market Breakup by Product
6.2.1 Antiprotozoal Therapeutics
6.2.2 Anthelminthic Therapeutics
6.2.3 Scabicides And Pediculicides Therapeutics
6.3 Figure: Global Parasitic Diseases Therapeutics Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
6.3.1 Antiprotozoal Therapeutics
6.3.2 Anthelminthic Therapeutics
6.3.3 Scabicides And Pediculicides Therapeutics
6.4 Chart: Global Parasitic Diseases Therapeutics Market Breakup by Region
6.4.1 North America
6.4.1.1 United States of America
6.4.1.2 Canada
6.4.2 Europe
6.4.2.1 Germany
6.4.2.2 France
6.4.2.3 United Kingdom
6.4.2.4 Italy
6.4.2.5 Others
6.4.3 Asia Pacific
6.4.3.1 China
6.4.3.2 Japan
6.4.3.3 India
6.4.3.4 ASEAN
6.4.3.5 Others
6.4.4 Latin America
6.4.4.1 Brazil
6.4.4.2 Argentina
6.4.4.3 Mexico
6.4.4.4 Others
6.4.5 Middle East and Africa
6.4.5.1 Saudi Arabia
6.4.5.2 United Arab Emirates
6.4.5.3 Nigeria
6.4.5.4 South Africa
6.4.5.5 Others
6.5 Figure: Global Parasitic Diseases Therapeutics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
6.5.1 North America
6.5.1.1 United States of America
6.5.1.2 Canada
6.5.2 Europe
6.5.2.1 Germany
6.5.2.2 France
6.5.2.3 United Kingdom
6.5.2.4 Italy
6.5.2.5 Others
6.5.3 Asia Pacific
6.5.3.1 China
6.5.3.2 Japan
6.5.3.3 India
6.5.3.4 ASEAN
6.5.3.5 Others
6.5.4 Latin America
6.5.4.1 Brazil
6.5.4.2 Argentina
6.5.4.3 Mexico
6.5.4.4 Others
6.5.5 Middle East and Africa
6.5.5.1 Saudi Arabia
6.5.5.2 United Arab Emirates
6.5.5.3 Nigeria
6.5.5.4 South Africa
6.5.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 EMR’s Key Indicators for Demand
10 EMR’s Key Indicators for Price
11 Competitive Landscape & Supplier Analysis
11.1 Bayer AG (ETR: BAYN)
11.1.1 Company Overview
11.1.2 Financial Analysis
11.2 F. Hoffmann-La Roche Ltd. (SWX: ROG)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.3 GlaxoSmithKline Plc (LON: GSK)
11.3.1 Company Overview
11.3.2 Financial Analysis
11.4 Pfizer Inc. (NYSE: PFE)
11.4.1 Company Overview
11.4.2 Financial Analysis
11.5 Sanaria Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.6 Others
12 Industry Events and Developments
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global therapeutic beds market attained a value of USD 3.37 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 5.38% to reach USD 4.61 billion...
The global allergy treatment market attained a value of 17.9 billion in 2020, driven by the growing popularity of immunotherapy. Aided by the growing R&D activities towards the development of anti-all...
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2021-2026 to attain a v...
The global sickle cell disease treatment market stood at a value of around USD 3.4 billion in 2020. The market is further expected to grow at a CAGR of 16.9% in the forecast period of 2021-2026 to att...
The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the ...
NEWSLETTER